Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

NCT00277017 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Kidney
Cancer

Interventions

DRUG: 5-Flourouracil, Interferon-a, IL-2 and Thalidomide

Sponsor

New Mexico Cancer Research Alliance